Terms of Use
The website www.sifigroup.com is SIFI  SPA.’s property, an Italian company with registered office in Lavinaio - Aci S. Antonio (CT), 95025 Via Ercole Patti 36, with VAT/Tax ID. n. 00122890874 © Copyright 2015 SIFI SPA.
SIFI SPA carries out, in the name and on behalf of the other companies of SIFI Group, all the activities related to the implementation, management and updating of the above -mentioned website.
 
These conditions of use apply to all content made available to the user in the portal www.sifigroup.com and constitute the entire agreement between the user and SIFI SPA regarding the use of this website and its contents.
 
All material published on this website (including artwork, graphics, photographs, images, screens, text, downloadable files, videos, trademarks, logos, product names, slogans) are SIFI SPA’s property and are protected by intellectual property rights, in accordance with the laws of Italy regarding the protection of copyright.
 
Access to the website via the URL www.sifigroup.com does not give the user the right to take possession of the information contained therein, nor to reproduce, modify, distribute, republish, in any form, even partial, and in any manner whatsoever without the express written consent of SIFI SPA.
 
SIFI SPA reserves the right to update, amend, integrate and/or delete the contents of this website at any time, including these Conditions of Use.
All changes to the Conditions of Use will become effective at the time they are published on this website. The access or use of the website following the updating of the Conditions of Use constitutes acceptance of those updated conditions.
"It's not what the vision is, it's what the vision does."
Peter Senge

On our Social Channels

From our News Center

Naples, 16 July 2018 09:30 to 16:30 Sala Posillipo, Eurostars Hotel Excelsior Via Partenope, 48, 80121 Naples ITALY Diabetic Macular Edema (EMD) is a degenerative ocular disease related...
 

 

13 June

SIFI to strengthen R&D Pipeline with Pro-Ocular™ containing a neurosteroid with novel dosage delivery system that activates neural signaling to produce endogenous...
Follow Us!